Relationship between clinical remission of perianal fistulas in Crohn's disease and serum adalimumab concentrations: A multi-center cross-sectional study

Crohn's disease (CD) is complicated by perianal fistulas in approximately 20% of patients. Achieving permanent fistula closure remains a challenge for physicians. An association between serum anti-tumor necrosis factor-α concentrations and clinical outcomes in patients with CD has been demonstr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	World journal of gastroenterology : WJG 2022-03, Vol.28 (9), p.961-972
Hauptverfasser:	Sirmai, Laura, Pelletier, Anne-Laure, Gault, Nathalie, Zallot, Camille, Bouguen, Guillaume, Bouchard, Dominique, Roland Nicaise, Pascale, Peyneau, Marine, Sironneau, Sandrine, Bittencourt, Marcelo De Carvalho, Petitcollin, Antoine, Fernandez, Pedro, Roblin, Xavier, Siproudhis, Laurent, Abramowitz, Laurent
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab - therapeutic use Crohn Disease - complications Crohn Disease - diagnosis Crohn Disease - drug therapy Cross-Sectional Studies Cutaneous Fistula - drug therapy Cutaneous Fistula - etiology Human health and pathology Humans Hépatology and Gastroenterology Life Sciences Observational Study Rectal Fistula - drug therapy Rectal Fistula - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!